Maas, R. J., Hoogstad-van Evert, J. S., Van der Meer, J. M., Mekers, V., Rezaeifard, S., Korman, A. J., . . . Dolstra, H. (2020). TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer. Oncoimmunology.
Citação norma ChicagoMaas, Ralph Ja, et al. "TIGIT Blockade Enhances Functionality of Peritoneal NK Cells With Altered Expression of DNAM-1/TIGIT/CD96 Checkpoint Molecules in Ovarian Cancer." Oncoimmunology 2020.
MLA CitationMaas, Ralph Ja, et al. "TIGIT Blockade Enhances Functionality of Peritoneal NK Cells With Altered Expression of DNAM-1/TIGIT/CD96 Checkpoint Molecules in Ovarian Cancer." Oncoimmunology 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.